Relaxometric investigations addressing the determination of intracellular water lifetime: a novel tumour biomarker of general applicability by Ruggiero, Maria Rosaria et al.
Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=tmph20
Molecular Physics
An International Journal at the Interface Between Chemistry and
Physics
ISSN: 0026-8976 (Print) 1362-3028 (Online) Journal homepage: https://www.tandfonline.com/loi/tmph20
Relaxometric investigations addressing the
determination of intracellular water lifetime: a
novel tumour biomarker of general applicability
Maria Rosaria Ruggiero, Simona Baroni, Silvio Aime & Simonetta Geninatti
Crich
To cite this article: Maria Rosaria Ruggiero, Simona Baroni, Silvio Aime & Simonetta Geninatti
Crich (2018): Relaxometric investigations addressing the determination of intracellular
water lifetime: a novel tumour biomarker of general applicability, Molecular Physics, DOI:
10.1080/00268976.2018.1527045
To link to this article:  https://doi.org/10.1080/00268976.2018.1527045
© 2019 The Author(s). Published by Informa
UK Limited, trading as Taylor & Francis
Group
Published online: 25 Sep 2018.
Submit your article to this journal 
Article views: 48
View Crossmark data
MOLECULAR PHYSICS
https://doi.org/10.1080/00268976.2018.1527045
NMR RELAXOMETRY AND RELATED METHODS
Relaxometric investigations addressing the determination of intracellular water
lifetime: a novel tumour biomarker of general applicability
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ABSTRACT
1H Fast-Field Cycling NMR relaxometry is proposed as a powerful method to investigate tumour cell
metabolism bymeasuring changes in cell water content andmobility across the cellular membrane.
Measurements of intracellular water residence time in cultured cells were carried out by measur-
ing T1 at fixed field (0.2 T) after the addition of a paramagnetic Gd complex (Prohance) at different
concentrations in the external medium. Investigations on tumour cells (mammary adenocarcinoma
TS/A) grown in normo- or hypoxic conditions or suspended in ‘hypo-osmotic’ solutions allowed us
to demonstrate that both hypoxic and hypo-osmotic conditions cause a marked increase in water
mobility as assessed by the elongation of T1. Conversely, themetabolic change caused by glutamine
(an aminoacid essential for tumour growth) deprivation caused a water mobility decrease (shorter
T1). These findings suggest that T1 measurements at low and variable magnetic field strengths, giv-
ing access to the assessment of intracellular water lifetime, can provide important information about
tumour cell metabolism in real time and non-invasively.
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1. Introduction
Intracellular water lifetime (τ in) has been recently sug-
gested as a new, promising cancer hallmark with the
potential to discriminate metabolic and microenviron-
mental states of tumour cells and their changes with
CONTACT Simonetta Geninatti Crich simonetta.geninatti@unito.it Department of Molecular Biotechnology and Health Sciences, University of
Torino, via Nizza 52, Torino 10126, Italy
therapy [1]. Mammalian cells regulate their volume to
prevent unintentional changes in intercellular signalling
and cell metabolism. Intentional cell volume changes
occur as cells undergo proliferation, apoptosis, or cell
migration [2]. To regulate their volume, cells use a
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number of channels and transport systems to flux
osmolytes across the plasma membrane, thus yielding a
concomitant movement of large quantities of water. It
follows that the intracellular lifetime of water molecules
(τ in) is the result of several contributions, amongst which
it is central the osmotically driven cytosolic membrane
water crossing and the overexpression/upregulation of
transporters such as GLUT-1, Na+/K+ ATP-ase and
aquaporins [3]. Recently, we reported that the 1/T1
NMRD profiles measured in vivo on implanted mam-
mary tumours unequivocally report on the change of
water amount and mobility in the pathological tissues
[4]. This result opens new horizons for the non-invasive
evaluation of tumour metabolic phenotypes, by pro-
viding useful and more detailed information related to
the metastatic propensity of the tumour. This finding
prompted us to apply a parallel relaxometric method-
ology that allows the ‘in vitro’ measurements of τ in of
cultured cells eventually undergone to different stimuli.
We expected that the acquisition of new data may shed
light on the different mechanisms at the basis of τ in
changes. In this context, hypoxia appears as an important
condition to be considered. In fact, hypoxia is a charac-
teristic feature of various solid tumours and is exploited
as a key marker for tumour progression and metastatic
spread [5,6]. Moreover, hypoxia limits the efficacy of
radio- and chemo-therapy and its changes can be used
to monitor early responses to therapy. Currently, there
is a great attention for diagnostic technologies able to
report on the hypoxia status of cancer lesions, as it would
enable clinical development of personalised, hypoxia-
based therapies, which, likely, will ultimately improve
outcomes. During anaerobic glycolysis, that occurs in
solid tumours under hypoxic conditions, there is a sig-
nificant increase of intracellular osmotic pressure due
to the production of the high amount of lactate [7,8].
Thus, glucose metabolism provides cells with osmotic
energy driving hydrodynamic work as well as the chemi-
cal energy that determine the rate of water exchange rate
(1/τ in) across the cellular membrane. The other stim-
uli, herein considered, deals with cell starvation induced
by glutamine (Gln) deprivation. In fact, recent studies
on metabolism indicated that utilisation of Gln is criti-
cal in tumour growth, progression, and development [9].
Exogenous Gln represents an additional carbon source
in cancer cells, to enhance the contribution arising from
glycolytic metabolites for energy production. During the
glycolytic process, Gln is converted to α-ketoglutarate by
glutaminase and glutamate dehydrogenase, which main-
tains cell growth and survival through the tricarboxylic
acid (TCA) cycle under glucose deprivation condition
[10]. Under normal cell conditions, small amounts of Gln
are consumed inmacromolecule biosynthesis and energy
formation. In this study, we aim at assessing changes in
τ in of cancer cells in response to the deprivation of Gln
with the intent of developing a diagnostic test able to
differentiate tumour from normal cells on the basis of
their different response to the aminoacid deprivation.
The quantitative determination of the cell membrane
permeability of a murine breast cancer cell line (TS/A)
[11,12] was carried out in vitro following an established
relaxometric procedure [13–16]. For this purpose, mea-
surements were carried out at the magnetic field of 0.5 T
in the presence of increasing amounts (5–40mM) of the
paramagnetic Gd-HPDO3A complex in the extracellu-
lar space of cellular suspensions. Then, these results were
validated with the acquisition of NMRD profiles of cel-
lular pellets that may be considered a ‘tissue like’ slice of
about 0.8 cm.
2. Material andmethods
2.1. Cell cultures
TS/A (kindly provided by prof. F. Cavallo’s group, Uni-
versity of Turin) were grown in RPMI 1640medium sup-
plemented with 10% fetal bovine serum (FBS), 100U/mL
Penicillin (P)with 100μg/ml Streptomycin (S) and 4mM
Glutamine (Gln). Cells were cultured in 5% CO2/95% air
at 37°C in a humidified chamber and were split every
2–3 days. All cells were tested negative for mycoplasma
byMycoAlertTM MycoplasmaDetectionKit. Allmaterials
were purchased from Lonza (Basel, Switzerland).
2.2. In vitro determination ofmembrane
permeability
TS/A cells (7 million) were detached with 0.05% trypsin
and 0.02% EDTA in PBS, washed once with PBS and
re-suspended in the presence of variable concentrations
of Gd-HPDO3A (5–40mM in PBS), kindly provided by
Bracco S.p.A. (Milan, Italy) [13]. Eu-HPDO3A was syn-
thetised as described in [17]. The relaxometric measure-
ments were carried out within 15min. The cells were
transferred in 5mm NMR tubes and centrifuged 5min
at 0.1 rcf (4°C). The measurements of the cellular pellet
were carried out at 0.5 T and 25°C on a Stelar SPIN-
MASTER spectrometer (Stelar, Mede, Italy) by means
of the inversion-recovery (IR) pulse sequence with 64 τ
increments.
2.3. FFC-NMR profiles
For FFC-NMR profiles 50 million of TS/A cells were
detached with 0.05% trypsin and 0.02% EDTA in PBS,
washed once with PBS. The cells were re-suspended in
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the presence of 1ml of phosphate buffer and were trans-
ferred in 5mm NMR tubes and centrifuged 15min at
0.2 rcf (4°C). The 1H profiles were measured over a con-
tinuum of magnetic field strength from 0.01 to 10MHz
proton Larmor frequency on the fast-field cycling relax-
ometer (SMARtracerTM, Stelar (Mede, PV)) at 25°C. Used
sequences were the Non Pre-Polarised (NP) sequence
between 10 and 7MHz and the Pre-Polarised (PP)
sequence between 7 and 0.01MHz [18]. The detection
and polarisation fields are set at 7 and 9MHz, respec-
tively. T1 was determined by the saturation recovery
method. Sixteen values of delay time (τ ) between pulses
were used. The reproducibility of the T1 data was± 5%.
2.4. H&E staining
TS/A cells were seeded in glass bottom confocal dishes
at a density of 50,000 of cells per well. After 24 h, they
were fixed with methanol at 4°C for 10min. The cells
were incubated for 5min in presence of haematoxylin
and then washed with tap water until it became clear.
Afterwards, they were incubated for 5min in presence of
eosin and then washed with tap water until it was clear.
The images were acquired at 40×magnification on Leica
3000 microscope.
2.5. MRI
MR images at 1 T were acquired with an Aspect M2-
High Performance MRI System (Aspect Magnet Tech-
nologies Ltd, Netanya, Israel) [19]. Glass capillaries
containing about 2× 106 cells were placed in an agar
phantom and MR imaging was performed by using
a standard T1-weighted multislice spin-echo sequence
(TR/TE/NEX = 800/8/4, FOV = 2.5 cm, NEX =
number of excitations; FOV = field of view).
2.6. ICP-MS
The final Gd and Eu concentrations were determined
by inductively coupled plasma mass spectrometry (ICP-
MS) (Element-2; Thermo-Finnigan, Rodano (MI), Italy).
Sample digestion was performed with 2ml of concen-
tratedHNO3 (70%) undermicrowave heating (Milestone
MicroSYNTHMicrowave Labstation).
2.7. NMRmeasurements and data analysis
In a cell suspension, water molecules distribute in the
extracellular (ex) space and in the intracellular (in) cyto-
plasm and exchange between the two compartments with
a water exchange rate of efflux kin (= τ in−1) and influx
kex (= τ ex−1), respectively. These parameters are related
by the equilibriummass balance kin·Vin = kex·Vex, where
Vin andVex (=1−Vin) are the intracellular and extracel-
lular volume fraction, respectively.
H2Oex
τ−1ex→ ←
τ−1in
H2Oin
From the relaxometric point of view, each environment
is characterised by its own longitudinal relaxation rate,
the extracellular (R1ex) and the intracellular one (R1in),
respectively.
In cell suspensions, without the addition of paramag-
netic contrast agents (CA), water exchange between the
two compartments occurs much faster than the recovery
of magnetisation due to T1, i.e. kex+ kin > > |R1ex −
R1in| (fast exchange limit). In this condition, water
molecules visit both compartments multiple times over
the magnetisation recovery. The time evolution of the
magnetisation in the IR experiment is monoexponential
and described by the following equation:
Mz = M0 · {1 − 2 · exp[−t(Vex · R1ex + Vin · R1in)]}
(1)
For the volume fraction determination, a 50 μM solution
of Eu-HPDO3A complex was added to the cell suspen-
sion (see below). This complex does not affect the relax-
ation rate of the extracellular compartment where remain
confined.
In the presence of a Gd-HPDO3A, confined into the
extracellular space, the condition kex+ kin ∼ |R1ex −
R1in| is met and the water exchange modulates the
observed relaxation behaviour, that is described by the
Bloch-McConnell equations [1,3,20]. The recovery of
longitudinal magnetisation after inversion is no longer
monoexponential (Figure 1) and is expressed as
Mz = M0 · {1 − 2[(1 − aS) · exp(−t · R1L)
+ aS · exp(−t · R1S)]} (2)
where Mz is the instantaneous magnetisation, M0 is its
Boltzmann equilibrium value, aL and R1L are the frac-
tion and rate constant for the apparent component with
the longer T1 (T1L = R1L–1), aS and R1S are the frac-
tion and rate constant for the apparent component with
the shorter T1 (T1S = R1S–1), and t is the running time
for recovery by relaxation. Because aL and aS are related
(aS+ aL = 1), there are only three independent parame-
ters: R1L, R1S, and aS (or aL), expressed as
R1ex = r1[CA] + R01ex (3)
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Figure 1. IR data of a TS/A sample in the presence of a 15mMGd-
HPDO3A solution (21.5MHz and 25°C). Datawere fitted according
to the 2SXmodel (black line, Equation (1)) and themonoexponen-
tial recovery (red line,Mz = M0(1–2exp(-t/T1))+ offset).
R1L = 12
(
R1in + R1ex + τ−1in +
Vin
τin(1 − Vin)
)
− 1
2
[(
R1in − R1ex + τ−1in −
Vin
τin(1 − Vin)
)2
+ 4Vin
τ 2in(1 − Vin)
] 1
2
(4)
R1S = 12
(
R1in + R1ex + τ−1in +
Vin
τin(1 − Vin)
)
+ 1
2
[(
R1in − R1ex + τ−1in −
Vin
τin(1 − Vin)
)2
+ 4Vin
τ 2in(1 − Vin)
] 1
2
(5)
aS = 12
⎛
⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
1 −
(R1in − R1ex)(1 − 2Vin)
+τ−1in +
Vin
τin(1 − Vin)[(
R1in − R1ex + τ−1in
− Vin
τin(1 − Vin)
)2
+ 4Vin
τ 2in(1 − Vin)
] 1
2
⎞
⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
(6)
where R1ex0 is the extracellular relaxation rate with no
CA, [CA] is the millimolar concentration of the CA in
the extracellular space and r1 is its relaxivity value.
The metal complex addition permits the V in and Vex
assessment by themeasurement of Gd and Eu concentra-
tions by inductively coupled plasma mass spectrometry
(ICP-MS; element-2; Thermo-Finnigan, Rodano (MI),
Italy). Since the metal complexes distribute only in Vex,
the latter was determined following the relationship:
Vex = nGd/Eu(mol)/(MGd/Eu(mol/l) ∗ Volp(l)) (7)
were nGd/Eu is the number of Gd or Eumoles determined
by ICP-MS; M is the concentration of the M-HPDO3A
solution (M = Gd or Eu) added to the cells, and Volp is
the volume of the wet cellular pellets.
From the experiments carried out in the presence of
Eu-HPDO3A, the relaxation rate values of the cytoso-
lic compartment R1in for TS/A was determined equal to
1.10 s−1, performing the fitting of the IR data according
to Equation (1), with fixed R1ex0 values of 0.4 s−1.
3. Results and discussion
In order to perform a quantitative analysis of water
dynamics in the different cell lines and to establish its
relationship with the FFC-NMR profile behaviour, the
assessment of the cell membrane permeability is cru-
cial. For this reason, a series of R1 measurements (0.5 T
and 25°C) were acquired by adding increasing amounts
(15–40mM) of Gd-HPDO3A to the extracellular space
of the TS/A cells grown in normo- and hypoxic con-
ditions, respectively. Hypoxic conditions were obtained
by culturing cells in a hypoxia incubator (CO2 5%, N2
94%, O2 1%) for one week. In order to avoid the inter-
nalisation of the metal complex, the addition of Gd-
HPDO3A was performed at 25°C and the relaxomet-
ric investigation was carried out within 15min. Then,
the IR data were analysed according to the two sites
(2SX) kinetic model [1,3,4, 20] using, as fitting con-
straints, the relaxation rate of the intra- and the extra-
cellular compartments in the absence of the paramag-
netic probe (1.10 and 0.4 s−1, respectively, see Mate-
rial and Methods), and the relaxivity of Gd-HPDO3A
(4.5 s−1mM−1). The obtained kinetic parameters are
reported in Table 1.
The most important result shown in Table 1 is the
significant decrease of the residence lifetime of water
molecules in cell cytoplasm (τ in) for cell grown under
hypoxic conditions. This behaviour is due to the hypoxia
induced switch of cells to the glycolytic phenotype. It
follows that the change in τ in can be exploited as a
Table 1. The kinetic parameters obtained by fitting theMz recov-
ery data for TS/A in normo and hypoxia conditions.
TS/A culture condition Intracellular residual lifetimeτ in (s)
Normoxia 0.039± 0.012 [4]
Hypoxia 0.013± 0.004
W/o Gln 0.095± 0.016
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Figure 2. FFC-NMR profiles acquired on TS/A cells grown in nor-
moxic (black stars) and hypoxic (black filled square) conditions.
The T1 were measured at 25°C; the mean± SD is calculated from
at least three independent experiments.
biomarker of this metabolic change. Then FFC-NMR
profiles of mammary adenocarcinoma cells (TS/A) cul-
tured for 1 week in normoxic or hypoxic conditions
were acquired at variable magnetic field strengths rang-
ing from 0.01 to 10MHz. For the acquisition of the FFC-
NMR profile, cells were detached by culture flasks with
trypsin, washedwith PBS and centrifuged in a 5mmglass
NMR tube to obtain a pellet 0.8–1 cm height after 15min
at 0.2 rcf. The viability of TS/A cells after the acquisi-
tion (30min) of the NMRD profile was determined by
trypan blue assay and it resulted to be higher than 85%.
The observed dispersion curve (Figure 2) is characteris-
tic of diamagnetic tissue relaxation [21,22]. T1 values of
TS/A cells grown in hypoxia are significantly longer than
normoxic one and the differences are inversely propor-
tional to the magnetic field strength (from 40 to 10% in
the range 0.01–10MHz).
The challenging hypothesis is that hypoxia induces cell
swelling with a consequent increase in the amount of
cytoplasmatic water and itsmobility, both changes result-
ing in longer T1 values. Cell histology, in particular, H&E
staining (Figure 3), confirmed the occurrence of cellular
swelling.
To support the view that the R1 decrease of the 1/T1
FFC-NMR profile is directly proportional to the osmot-
ically driven increase of the cytoplasmatic volume, FFC-
NMR profiles were acquired for TS/A, grown in nor-
moxic conditions, but incubated (for 10min) in a hypo-
osmotic buffer (220mOsm) prior to undergo to the pro-
file acquisition. Figure 4 shows that the obtained FFC-
NMR profile is similar to that of cells grown in hypoxic
Figure 3. Histology image of TS/A cells grown one week in nor-
moxia (blue panel) and hypoxia (green panel). Cells were stained
with haematoxylin and eosin. Magnification 40×. Images evi-
dence the increased cytoplasmatic volume of TS/A grown in
hypoxia condition.
conditions. From these preliminary data, one may sug-
gest that water exchange through cellmembranes can sig-
nificantly affect the T1 thus reporting non-invasively on
tumour characteristics that are fundamental for correct
prognosis and treatment decision.
On the contrary, MR images of cellular pellets
acquired at 1 T were unable to distinguish the cell pel-
lets grown in the normo- and hypoxic or in different
osmolarity conditions as shown in Figure 5.
With respect to the other methodologies currently
proposed for hypoxia imaging, the herein described
approach shows many advantages. For example, positron
emission tomography (PET) exploits the tracer [18F]
fluoromisonidazole ([18F]FMISO) [23,24], for hypoxia
molecular imaging. In hypoxic environments, [18F]
FMISO radical anion persists long enough to react with
macromolecules, trapping the tracer in the intracellu-
lar compartment. However, considering the low target-
to-background ratio and slow uptake in malignant tis-
sues, the use of [18F]FMISO was quite limited and new
tracers are still under scrutiny. On the contrary, the
relaxometric method herein described avoids the use
6 M. R. RUGGIERO ET AL.
Figure 4. FFC-NMR profiles acquired on TS/A cells grown in
normo (330mOsm, black stars) and hypo osmolar (225mOsm,
black filled circle) conditions. The T1 were measured at 25°C; the
mean± SD is calculated from at least three independent experi-
ments.
Figure 5. T1-weighted spin-echo MRI image (measured at 1T)
of an agar phantom containing TS/A cells grown in: normoxia,
hypoxia, 225mOsm, medium, 300mOsm medium (from the left
to the right, respectively).
of exogenous tracers being responsive to an endoge-
nous parameter, i.e. the osmotically driven changes of
water exchange rate. Oxygen enhanced MRI represents
another approach to hypoxia imaging [25]. It is based
on the use of molecular oxygen as a contrast agent as it
causes a decrease of R1 after its inhalation. In hypoxic
tissue, the inhaled oxygen molecules bind preferentially
to deoxygenated haemoglobin molecules, converting the
paramagnetic deoxyhaemoglobin to diamagnetic oxy-
haemoglobin. Therefore, hypoxic tumour regions can be
detected by the absence of measurable positiveR1. The
Figure 6. FFC-NMR profiles acquired on TS/A cells grown in the
absence (black filled square) and in the presence (4mM) of Gln
(black stars). The T1 values were measured at 25°C.
main limitation is thatR1 can be strongly influenced by
differences in gas delivery and inhalation.
Next, we assessed the change in the metabolism of
TS/A cells upon incubation for 24 h at 37°C (CO2 5%)
in a Gln free medium. Figure 6 shows the FFC-NMR
profiles acquired for TS/A grown in the presence and in
the absence of glutamine for 24 h. As shown in Figure
4, the differences are again inversely proportional to the
applied magnetic field strength with an increase of R1obs
at low field of ca. 30% in the absence of Gln. The τ in
was determined using the fixed field method described
above, i.e. in the presence of 5–20mM Gd-HPDO3A in
the extracellular space. Table 1 shows that Gln depriva-
tion causes a significant increase of τ in as a consequence
of the decrease of cellular metabolism. Gln is funda-
mental for highly proliferative cancer cells that use this
aminoacid as an essential substrate for energy source, as
well as for generation of nucleotides, lipids, and proteins.
This result suggests thatmeasurements of water exchange
rates can be used to distinguish between tumour and nor-
mal cells due to their different response to the change of
the amount of Gln present in the growing medium.
4. Conclusions
On the basis of the obtained results, one may con-
clude that variations of water exchange rates across the
intra- and extracellular compartments can be considered
as reporters of tumour metabolic status. In fact, water
dynamics in breast cancer cells (TS/A) grown in normo-
and hypoxic conditions and with and without the pres-
ence of glutamine in the incubation medium appears
significantly different. This difference can be exploited
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to obtain relevant physiological information for a
correct diagnosis, treatment decisions and monitoring in
oncology.
Moreover, changes in tissue water dynamics can be
monitored ‘in vitro’ and ‘in vivo’ by measuring FFC-
NMR 1/T1 dispersion profiles that strongly depend on
this parameter. Thus, FFC relaxometry may become a
paradigm-shifting technology which will generate new,
quantitative disease biomarkers, that will be spatially
detected in the images acquired on the FFC-MRI scan-
ners currently developed at Lurie’s lab in Aberdeen
[26,27].
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